SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

Murielle Rinaldi‐Carmona, Francis Barth, Michel Héaulme, +11

FEBS Letters

PharmacotherapyExperimental PharmacologyCannabinoid PharmacologySocial SciencesSelective Antagonist +16

SR 144528, the First Potent and Selective Antagonist of the CB2 Cannabinoid Receptor

M Rinaldi-Carmona, Francis Barth, J Millan, +11

Journal of Pharmacology and Experimental Therapeutics

Biochemical and pharmacological characterisatioN OF SR141716A, the first potent and selective brain cannabinoid receptor antagonist

Murielle Rinaldi‐Carmona, Francis Barth, Michel Héaulme, +6

Life Sciences

Cannabis UseMolecular PharmacologyFunctional SelectivityMedicineNeuropharmacology +12

Characterization and distribution of binding sites for [3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brain

Murielle Rinaldi‐Carmona, Françoise Pialot, Christian Congy, +6

Life Sciences

Cannabis UseRodent BrainFunctional SelectivityMedicineReceptor (Biochemistry) +10

Biochemical and pharmacological properties of SR 46349B, a new potent and selective 5-hydroxytryptamine2 receptor antagonist.

M Rinaldi-Carmona, Christian Congy, Vincent Santucci, +7

Journal of Pharmacology and Experimental Therapeutics

SR147778 [5-(4-Bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-N-(1-piperidinyl)-1 H-pyrazole-3-carboxamide], a New Potent and Selective Antagonist of the CB1 Cannabinoid Receptor: Biochemical and Pharmacological Characterization

Murielle Rinaldi‐Carmona, Francis Barth, Christian Congy, +9

Journal of Pharmacology and Experimental Therapeutics

Up-regulation of 5-HT2 receptors in the rat brain by repeated administration of SR 46349B, a selective 5-HT2 receptor antagonist

Murielle Rinaldi‐Carmona, Monsif Bouaboula, Christian Congy, +7

European Journal of Pharmacology Molecular Pharmacology

NeurophysiologyMedicine5-Ht2 ReceptorsRepeated AdministrationSr 46349B +11

Repeated administration of SR 46349B, a selective 5-hydroxytryptamine2 antagonist, up-regulates 5-hydroxytryptamine2 receptors in mouse brain.

M Rinaldi-Carmona, Christian Congy, Jacques Simiand, +4

Molecular Pharmacology

Identification of binding sites for SR 46349B, a 5-hydroxytryptamine2 receptor antagonist, in rodent brain

M Rinaldi-Carmona, Christian Congy, Philippe Pointeau, +3

Life Sciences

Rodent BrainNeurophysiologyNeuroanatomyMedicinePhysiology +12

Rational design of a novel peripherally-restricted, orally active CB1 cannabinoid antagonist containing a 2,3-diarylpyrrole motif

Laurent Hortala, Murielle Rinaldi‐Carmona, Christian Congy, +5

Bioorganic & Medicinal Chemistry Letters

2,3-Diarylpyrrole MotifCannabis UseMedicinal ChemistryPsychoactive DrugBiochemistry +11